secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2024-11-18T23:59:59+00:00
Accession:  0001213900-24-099327
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics implements 1-for-50 reverse stock split effective Nov 18, 2024
--------------------------------------------------------------------------------

- Reduces outstanding shares from ~27.6M to ~552,854, no change to par value $0.0001.
- No fractional shares; cash payment in lieu based on average closing price over ten days ending Nov 18.
- Trading symbol BJDX unchanged; new CUSIP 095633509.
- Proportionate adjustments to all outstanding equity awards and warrants.
- Stockholders with certificates receive instructions from exchange agent Continental Stock Transfer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024099327/0001213900-24-099327-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024099327/ea0221348-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-099327

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer